Parallel Advisors, LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1690010 SAN FRANCISCO, CA

Position in BCRX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$900

+$415 QoQ

Shares Held

+76.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#305

of 316 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $5,825,413 across 37 Drug Manufacturers - Specialty & Generic names. BCRX ranks #32 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	25,052	$1,800,236
2	RDY	Dr Reddys Laboratories Ltd	81,864	$1,186,209
3	UTHR	UNITED THERAPEUTICS Corp	1,130	$612,267
4	TAK	Takeda Pharmaceutical Co Ltd	28,293	$453,536
5	VTRS	Viatris Inc	25,192	$400,048
6	NBIX	Neurocrine Biosciences Inc	1,719	$289,720
7	PRGO	PERRIGO Co plc	16,056	$166,821
8	HLN	Haleon plc	16,900	$157,677

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$900	90	+76.5%	Shares	Sole	2026-08-05
2026-03-31	$485	51	-45.2%	Shares	Sole	2026-05-07
2025-12-31	$725	93	-35.0%	Shares	Sole	2026-02-11
2025-09-30	$1,085	143	+53.8%	Shares	Sole	2025-11-13
2025-06-30	$833	93	-31.6%	Shares	Sole	2025-07-08
2025-03-31	$1,020	136	+46.2%	Shares	Sole	2025-04-08
2024-12-31	$699	93	-25.0%	Shares	Sole	2025-02-10
2024-09-30	$942	124	+33.3%	Shares	Sole	2024-11-13
2024-06-30	$574	93	+132.5%	Shares	Sole	2024-08-08
2023-09-30	$283	40	+48.1%	Shares	Sole	2024-05-20
2023-06-30	$190	27	+170.0%	Shares	Sole	2024-05-20
2022-09-30	$126	10	+11.1%	Shares	Sole	2022-11-10
2022-03-31	$146	9	-50.0%	Shares	Sole	2022-04-28
2021-09-30	$258	18	—	Shares	Sole	2021-11-02
No filing history on record for this holder in this stock.